Preeclampsia
📧 Sign up to get email alerts when something new happens for Preeclampsia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: DM199 for Pregnancy Complications [NA]
DiaMedica Therapeutics has withdrawn its clinical trial of DM199 for pre-eclampsia.
-
CLINICAL_TRIALS withdrawal · 2025-04-04Clinical Trial Update: Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia [Phase 4]
A Phase 4 trial comparing universal aspirin to screening-indicated aspirin for the prevention of preeclampsia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-18Clinical Trial Update: The Impact of Pregnancy and Pregnancy-associated Hypertension on Human Uterine Myometrial Artery Reactivity
A clinical trial examining the impact of pregnancy and pregnancy-associated hypertension on uterine myometrial artery reactivity has been wi…
-
CLINICAL_TRIALS withdrawal · 2024-11-08Clinical Trial Update: Patient Satisfaction With Abbreviated Postpartum Magnesium Sulfate for Severe Preeclampsia [NA]
A clinical trial evaluating abbreviated postpartum magnesium sulfate for severe preeclampsia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-11-13Clinical Trial Update: Aspirin (ASA) Therapy and Preeclampsia Prevention [Phase 4]
A Phase 4 trial studying aspirin therapy for preeclampsia prevention has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-01-30Clinical Trial Update: Treatment Targets for Chronic Hypertension in Pregnancy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating treatment targets for chronic hypertension in pregnancy was withdrawn from the study record.
-
CLINICAL_TRIALS withdrawal · 2017-01-13Clinical Trial Update: Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial [Phase 2, Phase 3]
The clinical trial comparing labetalol to magnesium sulfate for prevention of eclampsia (NCT00293735) has been withdrawn from Phase 2/3 deve…
-
CLINICAL_TRIALS withdrawal · 2016-09-07Clinical Trial Update: Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean [Phase 3]
Phase 3 trial evaluating the use of vasopressors to treat hypotension during spinal anesthesia for cesarean delivery was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-13Clinical Trial Update: Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia [Phase 2]
A Phase 2 clinical trial evaluating a COX-2 inhibitor for the treatment of Preeclampsia has been withdrawn.